Monte Rosa Therapeutics Inc
NASDAQ:GLUE 10:38:12 AM EDT
Earnings Announcements
Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results And Business Updates
Published: 05/11/2022 11:40 GMT
Monte Rosa Therapeutics Inc (GLUE) - Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results and Business Updates.
Monte Rosa Therapeutics - Expects Cash and Cash Equivalents Will Be Sufficient to Fund Planned Operations and Capital Expenditures Into Late 2024.
Qtrly Net Loss per Share Attributable to Common Stockholders Basic and Diluted $0.51.
Q1 Earnings per Share View $-0.52 -- Refinitiv Ibes Data (analyst estimates).
Monte Rosa Therapeutics - Expects Cash and Cash Equivalents Will Be Sufficient to Fund Planned Operations and Capital Expenditures Into Late 2024.
Qtrly Net Loss per Share Attributable to Common Stockholders Basic and Diluted $0.51.
Q1 Earnings per Share View $-0.52 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.54
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.54
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57
More details on our Analysts Page.